Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Blumenstein

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1990
Combined versus sequential chemo-endocrine therapy in advanced prostate cancer: final results of a randomized Southwest Oncology Group studyC K Osborne, B Blumenstein, E D Crawford, et al.
American Journal of Human Biology : the Official Journal of the Human Biology Council|June 1, 2017
Physiological and cognitive responses to cold exposure in 11-12-year-old boysB Falk, M Bar-Eli, R Dotan, et al.
Controlled Clinical Trials|June 1, 1995
Design of the Prostate Cancer Prevention Trial (PCPT)P Feigl, B Blumenstein, I Thompson, et al.
Seminars in Oncology|October 1, 1994
Prognostic factors in stage D2 prostate cancer; important implications for future trials: results of a cooperative intergroup study (INT.0036). The National Cancer Institute Intergroup Study #0036M A Eisenberger, E D Crawford, M Wolf, et al.
Progress in Clinical and Biological Research|January 1, 1989
Adriamycin versus BCG in superficial bladder cancer: a Southwest Oncology Group StudyD L Lamm, J Crissmann, B Blumenstein, et al.
The Journal of Urology|July 1, 1992
Combination cisplatin and dichloromethotrexate in patients with advanced bladder cancer. Phase 2. A Southwest Oncology Group studyF J Meyers, B Blumenstein, E D Crawford, et al.
American Journal of Clinical Oncology|October 1, 1995
Phase II trial of CHIP for the treatment of advanced, hormonally refractory carcinoma of the prostate. A Southwest Oncology Group StudyM E Marshall, M K Wolf, E D Crawford, et al.
Investigational New Drugs|May 1, 1993
Phase II trial of echinomycin for the treatment of advanced renal cell carcinoma. A Southwest Oncology Group studyM E Marshall, M K Wolf, E D Crawford, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Borealis-1: a randomized, first-line, placebo-controlled, phase II study evaluating apatorsen and chemotherapy for patients with advanced urothelial cancerJ Bellmunt, B J Eigl, E Senkus, et al.
European Urology|April 15, 2000
The prognostic significance of S-phase analysis in stage Ta/T1 bladder cancer. A Southwest Oncology Group StudyR W deVere White, A D Deitch, S Daneshmand, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1990
Combined versus sequential chemo-endocrine therapy in advanced prostate cancer: final results of a randomized Southwest Oncology Group studyC K Osborne, B Blumenstein, E D Crawford, et al.
American Journal of Human Biology : the Official Journal of the Human Biology Council|June 1, 2017
Physiological and cognitive responses to cold exposure in 11-12-year-old boysB Falk, M Bar-Eli, R Dotan, et al.
Controlled Clinical Trials|June 1, 1995
Design of the Prostate Cancer Prevention Trial (PCPT)P Feigl, B Blumenstein, I Thompson, et al.
Seminars in Oncology|October 1, 1994
Prognostic factors in stage D2 prostate cancer; important implications for future trials: results of a cooperative intergroup study (INT.0036). The National Cancer Institute Intergroup Study #0036M A Eisenberger, E D Crawford, M Wolf, et al.
Progress in Clinical and Biological Research|January 1, 1989
Adriamycin versus BCG in superficial bladder cancer: a Southwest Oncology Group StudyD L Lamm, J Crissmann, B Blumenstein, et al.
The Journal of Urology|July 1, 1992
Combination cisplatin and dichloromethotrexate in patients with advanced bladder cancer. Phase 2. A Southwest Oncology Group studyF J Meyers, B Blumenstein, E D Crawford, et al.
American Journal of Clinical Oncology|October 1, 1995
Phase II trial of CHIP for the treatment of advanced, hormonally refractory carcinoma of the prostate. A Southwest Oncology Group StudyM E Marshall, M K Wolf, E D Crawford, et al.
Investigational New Drugs|May 1, 1993
Phase II trial of echinomycin for the treatment of advanced renal cell carcinoma. A Southwest Oncology Group studyM E Marshall, M K Wolf, E D Crawford, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Borealis-1: a randomized, first-line, placebo-controlled, phase II study evaluating apatorsen and chemotherapy for patients with advanced urothelial cancerJ Bellmunt, B J Eigl, E Senkus, et al.
European Urology|April 15, 2000
The prognostic significance of S-phase analysis in stage Ta/T1 bladder cancer. A Southwest Oncology Group StudyR W deVere White, A D Deitch, S Daneshmand, et al.
Pageof 4